The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Scientists provide evidence for the existence of four-stranded human DNA, which has previously only been theorized and synthesized.
A new technique simplifies and accelerates the development of tests for identifying potential biological weapons.
Using surface plasmon resonance to improve antibody detection and characterization: four case studies
A deadly mushroom toxin shrinks pancreatic tumors in mice.
Turning a standard technique into an unbiased screen for diagnostic biomarkers
An adenovirus isolated from chimpanzee feces proves more effective than human adenoviruses as a vaccine vector for hepatitis C.
Researchers have developed a way to activate cancer fighting drugs by pulsing them with light, which could make such therapies safer.
A new antibody cocktail can remove undifferentiated, tumor-forming cells from a mix of embryonic stem cells.
Repurposing patient’s own T-cells to recognize antigens on cancer cells caused dramatic improvement in three patients with chronic lymphocytic leukemia.